Meet the Team

The researchers and communicators behind BreathPharma


Abel Biirbaare Daartey headshot

Abel Biirbaare Daartey, PharmD

PhD Candidate · Pharmacology & Pediatric Oncology
Founder, BreathPharma


Hi, I’m Daartey, a PharmD-trained PhD candidate in Pharmaceutical Sciences, with a research focus on childhood cancers that too often go undertreated and underfunded.

My work centres on neuroblastoma and medulloblastoma, two of the most aggressive paediatric cancers, each arising in a child’s developing nervous system. I study the molecular signals that drive these tumours: what makes them grow, what makes them resist treatment, and where we can intervene. That means investigating signalling pathways like MAPK/ERK and PI3K/AKT, essentially the communication networks cancer cells hijack, as well as epigenetic mechanisms that silently reshape how genes behave without changing the DNA itself.

I chose this field because children with these cancers deserve more than scaled-down adult treatments. They deserve therapies designed specifically for them. BreathPharma is my commitment to making the science behind that effort accessible, written rigorously, but for everyone.

Abosede Salami

PhD Candidate · Medicinal Chemistry & Drug Discovery
Contributing Author & Editor, BreathPharma


Hi, I’m Abosede, a PhD candidate in Pharmaceutical Sciences with a concentration in Medicinal Chemistry. My research focuses on the discovery and development of selective PARP2 inhibitors as potential therapies for prostate cancer, with a particular interest in how targeted small molecules can modulate cancer-driving pathways and improve treatment outcomes.

My work sits at the intersection of medicinal chemistry, drug discovery, chemical biology, and oncology. From designing and synthesising novel compounds to evaluating their biological activity, I am fascinated by the process of transforming scientific ideas into potential therapeutic solutions.

Beyond the laboratory, I am passionate about the future of pharmaceutical innovation, scientific communication, and expanding opportunities for the next generation of scientists. Through BreathPharma, I share insights on drug discovery, medicinal chemistry, pharmaceutical research, emerging technologies, career development, and the evolving landscape of healthcare innovation.

I believe that great medicines begin with great science, but their true impact is realised only when knowledge is shared, translated, and applied to improve lives.


Our Approach to Science Communication

Every article on BreathPharma is written by a domain expert and reviewed for accuracy before publication. We cite our sources, explain our reasoning, and write for readers, not algorithms.